Hepatolenticular Degeneration

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2024-03-26
EMA Authorised: Cuprior (trientine tetrahydrochloride) — Orphalan
Cuprior (trientine tetrahydrochloride) has been authorised in the European Union for hepatolenticular degeneration.